Success Metrics

Clinical Success Rate
100.0%

Based on 29 completed trials

Completion Rate
100%(29/29)
Active Trials
0(0%)
Results Posted
100%(29 trials)

Phase Distribution

Ph phase_2
2
7%
Ph phase_3
7
24%
Ph phase_1
20
69%

Phase Distribution

20

Early Stage

2

Mid Stage

7

Late Stage

Phase Distribution29 total trials
Phase 1Safety & dosage
20(69.0%)
Phase 2Efficacy & side effects
2(6.9%)
Phase 3Large-scale testing
7(24.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

29 of 29 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

29

all time

Status Distribution
Completed(29)

Detailed Status

Completed29

Development Timeline

Analytics

Development Status

Total Trials
29
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 120 (69.0%)
Phase 22 (6.9%)
Phase 37 (24.1%)

Trials by Status

completed29100%

Recent Activity

0 active trials
Showing 5 of 29
completedphase_3

A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)

NCT04605991
completedphase_3

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes

NCT03952130
completedphase_2

A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes

NCT04585776
completedphase_3

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

NCT03952143
completedphase_3

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes

NCT03740919
View all 29 trials

Clinical Trials (29)

Showing 20 of 29 trialsScroll for more
NCT04605991Phase 3

A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)

Completed
NCT03952130Phase 3

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes

Completed
NCT04585776Phase 2

A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes

Completed
NCT03952143Phase 3

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

Completed
NCT03740919Phase 3

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes

Completed
NCT04049123Phase 1

A Study of LY900014 in Healthy Chinese Participants

Completed
NCT04276207Phase 1

A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps

Completed
NCT03760640Phase 2

A Study of LY900014 in a Medtronic Pump

Completed
NCT03465878Phase 1

A Study of LY900014 in Participants With Type 1 Diabetes Mellitus

Completed
NCT02703337Phase 1

A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy

Completed
NCT02703350Phase 1

A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy

Completed
NCT02703324Phase 1

A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps

Completed
NCT03341312Phase 1

A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)

Completed
NCT02770521Phase 1

A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants

Completed
NCT03305822Phase 1

A Study of LY900014 in Participants With Type 2 Diabetes Mellitus

Completed
NCT02525744Phase 1

A Study of a New LY900014 Formulation in Healthy Participants

Completed
NCT03341299Phase 1

A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus

Completed
NCT02636361Phase 1

A Study of Various Formulations of LY900014 in Healthy Participants

Completed
NCT02317575Phase 1

A Study of LY900014 Formulations in Healthy Participants

Completed
NCT03214367Phase 3

A Study of LY900014 in Participants With Type 1 Diabetes

Completed

Drug Details

Intervention Type
DRUG
Total Trials
29